Protagonist Therapeutics (PGF) Revenue

1 Followers

Protagonist Therapeutics Revenue

Protagonist Therapeutics had a revenue of 213.47M in the quarter ending Jun 30, 2026, with 278.72%. This bring the company's revenue in the last twelve months to 281.99M, Decreased 280.75%. In the fiscal year ending Dec 31, 2025, Protagonist Therapeutics had annual revenue of 46.02M with -89.41% growth.

Revenue (ttm)

281.99M

Revenue Growth

―

P/S Ratio

180.57

Revenue/Employee

€326,355

Employees

141

Market Cap

€8.31B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	46.02M	-388.42M	-89.41%
Dec 31, 2024	434.43M	374.43M	+624.06%
Dec 31, 2023	60.00M	33.42M	+125.73%
Dec 31, 2022	26.58M	-776.00K	-2.84%
Dec 31, 2021	27.36M	-1.27M	-4.44%
Dec 31, 2020	28.63M	28.40M	+12,293.07%
Dec 31, 2019	231.00K	-30.69M	-99.25%
Dec 31, 2018	30.93M	10.86M	+54.14%
Dec 31, 2017	20.06M	―	―